1151588

Melinta Therapeutics, LLC. — FEI 3015059178

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 27, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)